AI
IART icon

Atom Investors’s Integra LifeSciences IART Stock Holding History

Atom Investors’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-33,117
Closed -$1.49M – 607
2018
Q4 		$1.49M Buy
+33,117
New +$1.82M 0.15% 177

Other funds holding IART

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Atom Investors's IART Position: Q1 2019 in Review

Atom Investors sold out of Integra LifeSciences (IART) in Q1 2019, closing a stake of 33,117 shares — an estimated $1.49M sold.

Atom Investors first reported a position in IART in Q4 2018 and held it in 1 quarter. The position peaked at $1.49M in Q4 2018. 259 funds tracked by Wall St. Rank hold IART as of Q1 2019.

  • Atom Investors reported no remaining Integra LifeSciences position as of Q1 2019 after selling out during the quarter.
  • Atom Investors sold 33,117 Integra LifeSciences shares in Q1 2019, an estimated $1.49M.
  • Atom Investors first reported a position in Integra LifeSciences in Q4 2018 and held it in 1 quarter.
  • Atom Investors's Integra LifeSciences position peaked at $1.49M in Q4 2018.
  • 259 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2019.

Based on Atom Investors's 13F filing for Q1 2019, filed 15 May 2019.